FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MARK REUBEN 		2. Issuer Name and Ticker or Trading Symbol

COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

11/5/2007
(Street)

NEW YORK, NY 10022
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   (1)                6155150   D  
 
Common Stock   11/5/2007     M (2)    520000   A $46.7813   6675150   D  
 
Common Stock   11/5/2007     M (2)    520000   A $43.6625   7195150   D  
 
Common Stock   11/5/2007     M (2)    520000   A $40.5438   7715150   D  
 
Common Stock   11/5/2007     M (2)    520000   A $37.425   8235150   D  
 
Common Stock   11/5/2007     M (2)    520000   A $34.3063   8755150   D  
 
Common Stock   11/5/2007     M (2)    1300000   A $53.0188   10055150   D  
 
Common Stock   11/5/2007     F (3)    3133525   D $75.37   6921625   D  
 
Common Stock   11/6/2007     S (4)    285000   D $75.3697   (4) 6636625   D  
 
Common Stock   11/5/2007     M (5)    1300000   A $53.0188   1300000   I   By LLC   (5)
Common Stock   11/5/2007     F (6)    914482   D $75.37   385518   I   By LLC   (5)
Common Stock                  300000   I   By LLC   (7)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $34.3063   11/5/2007     M  (2)       520000    11/7/1998   (8) 11/6/2007   Common Stock   520000   $0   0   D  
 
Stock Option (Right to Buy)   $37.425   11/5/2007     M  (2)       520000    11/7/1999   (8) 11/6/2007   Common Stock   520000   $0   0   D  
 
Stock Option (Right to Buy)   $40.5438   11/5/2007     M  (2)       520000    11/7/2000   (8) 11/6/2007   Common Stock   520000   $0   0   D  
 
Stock Option (Right to Buy)   $43.6625   11/5/2007     M  (2)       520000    11/7/2001   (8) 11/6/2007   Common Stock   520000   $0   0   D  
 
Stock Option (Right to Buy)   $46.7813   11/5/2007     M  (2)       520000    11/7/2002   (8) 11/6/2007   Common Stock   520000   $0   0   D  
 
Stock Option (Right to Buy)   $53.0188   11/5/2007     M  (2)       1300000    11/7/2002   (8) 11/6/2007   Common Stock   1300000   $0   0   D  
 
Stock Option (Right to Buy)   $53.0188   11/5/2007     M  (2)       1300000    11/7/2002   (8) 11/6/2007   Common Stock   1300000   $0   0   I   By LLC   (5)

Explanation of Responses:
( 1)  This line shows Mr. Mark's direct holdings of common stock of the Company prior to the transactions reported on this form.
( 2)  This report relates to Mr. Mark's exercise of expiring stock options granted in 1997 under the Company's employee stock option plan, his only remaining options granted during his tenure as CEO. The options were granted in several tranches, shown separately on this form, with premium strike prices ranging from 10% to 70% over the market price of the common stock on the date of grant. In addition, the options were subject to early expiration if the common stock price did not reach certain hurdle rates (50% appreciation within 5 years and 70% appreciation within 7 years). During the ten-year period the options were in effect, the total shareholder return on the Company's common stock was 174% versus 92% for the S&P 500 and 140% for the peer group used by Colgate in its proxy statement performance graph, and the Company's market capitalization increased from $18.5 billion to $38.4 billion. The net effect of the option exercise and other transactions reported on this form was to increase Mr. Mark's holdings of Colgate Common Stock.
( 3)  The exercise price of the options and related withholding requirement was satisfied by the Company's withholding shares otherwise deliverable upon exercise of the options.
( 4)  Purpose of share sale was to help fund income taxes in connection with this option exercise and retirement distributions to Mr. Mark as a result of his retirement as Chief Executive Officer of the Company on July 1, 2007. Shares were sold on November 6, 2007, at the average price shown above, in 30 lots at prices ranging from $75.08 to $75.50.
( 5)  In 1998 Mr. Mark transferred this portion of the 1997 option grant to a family limited liability company owned by Mr. Mark's spouse and several trusts for the benefit of his children and grandchildren ("LLC"), which also exercised the options transferred to it at the end of their term. Mr. Mark disclaims beneficial ownership in the shares held by the LLC to the extent he has no pecuniary interest therein.
( 6)  The exercise price of the options held by the family LLC was satisfied by the Company's withholding shares otherwise deliverable upon exercise of the options.
( 7)  Mr. Mark holds these shares through an LLC of which he is the sole member.
( 8)  Option became 100% exercisable on the date shown in this column.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MARK REUBEN
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK, NY 10022 		X



Signatures
Reuben Mark 11/7/2007
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Colgate Palmolive Charts.
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Colgate Palmolive Charts.